Fabrice Verriele

Rarecells Diagnostics SAS is a French company passionate about saving lives by detecting and eliminating cancer at its start. The company is based in Paris, France and was founded by Patrizia Paterlini-Bréchot, who has been the CEO since incorporation. The company believes that accurate, early cancer detection has the potential to save millions of lives. Rarecells Diagnostics has developed the ISET blood filtration technology, which enables cell culture to generate xenograph of avatars. The company is currently conducting three clinical studies to evaluate the performance of their dedicated ISET-based assay to allow early detection of prostate cancer. The company is also developing a multi-cancer test for early cancer diagnosis and is working with researchers to propel care forward.

The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris.

Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland.

Institut Pasteur Korea Research Foundation provides research and development for the treatment of infectious and chronic diseases. It develops a technology-based approach to therapeutic development through cellular models, high content screening and medicinal chemistry. The company was founded on December 29, 2003 and is headquartered in Seongnam, South Korea.

ScreenCell SA provides access to circulating rare cells. It offers rare cell isolation solutions for medical and research applications. The company was founded by Patrizia Paterlini-Brechot, Ian Jones and Christian Brechot on April 11, 2001 and is headquartered in Sarcelles, France.

Global Virus Network conducts research on essential and critical defense against viral diseases. The non-profit company is based in Baltimore, MD. The company was founded by William Walmsley Hall and Robert C. Gallo.

Ginger SA provides engineering and construction services. The firm also offers consulting, engineering, construction and maintenance services for telecom network infrastructures. The company was founded in 1997 and is headquartered in Paris, France.

Assurances & Conseils Saint-Honoré is a company based in Paris, France. Part of Newstone Courtage SA, Assurances & Conseils Saint-Honoré provides risk protection and related insurance products. The CEO of the French company is Pierre Leonard Georg Donnersberg.

Part of Newstone Courtage SA, MSH International (Canada) Ltd. provides expatriate insurance products. The company is based in Montréal, Canada.

Part of Edmond de Rothschild SA, Cie Financière Saint-Honoré SA is a French Paris-based company that provides investment banking services.

SIACI Saint Honoré SAS provides insurance brokerage and consulting services. It specializes in health and life, employee pension savings and retirement plans, total rewards, prevention and well-being, employee benefits, international pension plans, and mobility services. The firm serves the agro-industrial, logistics, engineering, construction, and media sectors. The company was founded in 1932 and is headquartered in Paris, France.

SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France.

Institut de la Vision is a research center located in Paris, France that focuses on discovering, developing, and testing treatments and technological innovations for eye diseases. The French company's objective is to improve the autonomy and quality of life of patients. The private company was founded by José-Alain Sahel.

Institut de France engages in the development of the arts and sciences. Its goal is to improve the arts and sciences in line with the principle of pluridisciplinarity and manage the thousands of donations, legacies, and foundations. The company was founded in 1795 and is headquartered in Paris, France.

UPMC Enterprises (UPMC Enterprises) is a venture capital subsidiary of University of Pittsburgh Medical Center founded in 2014. The firm is headquartered in Pittsburgh, Pennsylvania.

Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA.

Compagnie Mérieux Alliance SAS owns shares and interests in firms that manufactures, sells, and distributes medicines and other pharmaceutical products. The company is headquartered in Lyon, France.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.